Factors to Consider Regarding the Need for Inferior Vena Cava Filters

Prog Cardiovasc Dis. 2018 Mar-Apr;60(6):622-628. doi: 10.1016/j.pcad.2018.04.005.

Abstract

There continues to be controversy on the use of inferior vena cava (IVC) filters in patients with deep venous thrombosis, pulmonary embolism, and venous thromboembolism. In this state of the art review, the benefits and risks of IVC filters are discussed. Based on the current state of knowledge regarding the efficacy and risks of this therapy, guidelines are suggested regarding the patients who need and who do not need this expensive, risky, but potentially life-saving therapy.

Keywords: Inferior vena cava filter; deep vein thrombosis; pulmonary embolism; venous thromboembolism.

Publication types

  • Review

MeSH terms

  • Anticoagulants / administration & dosage*
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Prognosis
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / therapy*
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome
  • Vena Cava Filters / adverse effects
  • Vena Cava Filters / statistics & numerical data*
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / mortality
  • Venous Thromboembolism / therapy

Substances

  • Anticoagulants